- News & Analysis
- Home
- Latest News
- Reports
- Podcasts
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Page 384
Contrary Capital boots up fund
The fund, which has already made its first investments, will offer between $50,000 and $200,000 to both spinouts and student startups.
Sep 22, 2017ZhongAn zips in to close $1.5bn IPO
SoftBank bought $500m of shares as online insurance platform ZhongAn priced the largest ever fintech IPO in Hong Kong, giving exits to Ping An, Tencent and Ant Financial.
Sep 22, 2017Weiying finds Maoyan merger just the ticket
Corporate-backed online ticketing service Weiying is set to merge several of its assets with peer Maoyan, which is majority owned by Enlight Media.
Sep 22, 2017YH Global signs for $182m delivery
Shenzhen Grandland Group has taken part in a series A round for supply chain services provider YH Global, which operates logistics centres in more than 50 Chinese cities.
Sep 22, 2017BMW grasps DSP Concepts in $10m round
BMW i Ventures has led a series A round for DSP Concepts, the creator of software that helps developers add voice control to their products.
Sep 22, 2017Mahindra senses Cloudleaf for $13m series A
Industrial internet-of-things technology developer Cloudleaf will use the proceeds from its Mahindra Group-backed series A round for innovation and product commercialisation.
Sep 22, 2017ThinkCerca writes up series B round
TAL Education and existing investor Follett Corporation were among the participants in a $10.1m round that took the total raised by the critical skills learning platform to $14.8m.
Sep 22, 2017Vexata defines $54m series A
Intel Capital has participated in an inaugural funding round for Vexata, which has just released its data storage technology platform.
Sep 21, 2017Luno pockets $9m series B round
The digital wallet operator has raised $9m in a series B round that will help consolidate its product launch in 40 different markets.
Sep 21, 2017Disarm persuades investors for series A
AbbVie Ventures is among the backers of a $30m series A round for Disarm Therapeutics, a biotechnology spinout from Washington University in St Louis.
Sep 21, 2017About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


